Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
PHARMATROPHIX INC
See All Filings
|
D | 2014-07-08 |
Amount To Be Raised
$9,500,000
Associated Brokers / Dealers
N/A
CIK Number
0001425819
Filed Document
0001425819-14-000001
Exclusions or Exemptions
506b
Accepted Date
2014-07-08
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PHARMATROPHIX INC
See All Filings
|
D/A | 2015-11-20 |
Amount To Be Raised
$10,300,000
Associated Brokers / Dealers
N/A
CIK Number
0001425819
Filed Document
0001425819-15-000001
Exclusions or Exemptions
506b
Accepted Date
2015-11-20
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PHARMATROPHIX INC
See All Filings
|
D | 2010-03-15 |
Amount To Be Raised
$179,936
Associated Brokers / Dealers
N/A
CIK Number
0001425819
Filed Document
0001425819-10-000001
Exclusions or Exemptions
N/A
Accepted Date
2010-03-15
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PHARMATROPHIX INC
See All Filings
|
D | 2012-09-10 |
Amount To Be Raised
$2,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001425819
Filed Document
0001425819-12-000001
Exclusions or Exemptions
N/A
Accepted Date
2012-09-10
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PHARMATROPHIX INC
See All Filings
|
D | 2013-10-25 |
Amount To Be Raised
$250,000
Associated Brokers / Dealers
N/A
CIK Number
0001425819
Filed Document
0001425819-13-000001
Exclusions or Exemptions
506b
Accepted Date
2013-10-25
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|